How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
56
VRSK Quote, Financials, Valuation and Earnings
Last price:
$292.61
Seasonality move
:
7.07%
Day range:
$281.87 - $294.70
52-week range:
$217.34 - $306.68
Dividend yield:
0.57%
P/E ratio:
42.44x
P/S ratio:
14.09x
P/B ratio:
398.48x
Volume:
841.4K
Avg. volume:
1.1M
1-year change:
27.79%
Market cap:
$39.9B
Revenue:
$2.9B
EPS (TTM):
$6.70
Analysts' Opinion
-
Consensus RatingVerisk Analytics has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $294.02, Verisk Analytics has an estimated upside of 3.4% from its current price of $284.35.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $230.00 representing 100% downside risk from its current price of $284.35.
Fair Value
-
According to the consensus of 14 analysts, Verisk Analytics has 3.4% upside to fair value with a price target of $294.02 per share.
VRSK vs. S&P 500
-
Over the past 5 trading days, Verisk Analytics has underperformed the S&P 500 by -0.36% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Verisk Analytics does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Verisk Analytics has grown year-over-year revenues for 9 quarters straight. In the most recent quarter Verisk Analytics reported revenues of $735.6M.
Earnings Growth
-
Verisk Analytics has grown year-over-year earnings for 7 quarters straight. In the most recent quarter Verisk Analytics reported earnings per share of $1.49.
Enterprise value:
42.6B
EV / Invested capital:
--
Price / LTM sales:
14.09x
EV / EBIT:
31.50x
EV / Revenue:
14.79x
PEG ratio (5yr expected):
0.71x
EV / Free cash flow:
46.32x
Price / Operating cash flow:
44.14x
Enterprise value / EBITDA:
25.69x
Gross Profit (TTM):
$2B
Return On Assets:
21.33%
Net Income Margin (TTM):
33.24%
Return On Equity:
329.21%
Return On Invested Capital:
29.61%
Operating Margin:
43%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.5B | $2.7B | $2.9B | $677.2M | $735.6M | |
| Gross Profit | $1.7B | $1.8B | $2B | $451M | $505.1M | |
| Operating Income | $1.4B | $1.1B | $1.3B | $250.5M | $316.3M | |
| EBITDA | $1.7B | $1.4B | $1.7B | $356.9M | $386M | |
| Diluted EPS | $5.96 | $4.20 | $6.70 | $1.19 | $1.49 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $794.2M | $907.4M | $925.1M | $810.1M | $911.6M | |
| Total Assets | $7.6B | $7.8B | $7B | $4.4B | $4.3B | |
| Current Liabilities | $1.4B | $1.8B | $2.3B | $771.4M | $1.2B | |
| Total Liabilities | $4.9B | $5B | $5.2B | $4B | $4.2B | |
| Total Equity | $2.7B | $2.8B | $1.8B | $322.2M | $105M | |
| Total Debt | $3.2B | $3.3B | $3.7B | $2.8B | $3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.1B | $1.1B | $1.1B | $252.4M | $255.4M | |
| Cash From Investing | $301.4M | $2.7B | -$124.8M | -$57M | -$48.4M | |
| Cash From Financing | -$1.3B | -$3.8B | -$1B | -$295.1M | -$370.3M | |
| Free Cash Flow | $784.3M | $830.7M | $920.1M | $196.1M | $200M | |
VRSK
Sector
Market Cap
$39.9B
$574.7M
Price % of 52-Week High
92.72%
69.72%
Dividend Yield
0.57%
0%
Shareholder Yield
3.18%
2.29%
1-Year Price Total Return
27.79%
-9.87%
Beta (5-Year)
0.877
0.764
Dividend yield:
0.57%
Annualized payout:
$1.56
Payout ratio:
23.1%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$290.84
200-day SMA
Buy
Level
$279.52
Bollinger Bands (100)
Sell
Level
279.36 - 295.26
Chaikin Money Flow
Buy
Level
198.5M
20-day SMA
Sell
Level
$291.23
Relative Strength Index (RSI14)
Sell
Level
44.04
ADX Line
Sell
Level
13.2
Williams %R
Neutral
Level
-67.8262
50-day SMA
Sell
Level
$292.39
MACD (12, 26)
Sell
Level
-0.42
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Neutral
Level
224.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.5574)
Sell
CA Score
(Annual)
Level (-0.867)
Buy
Beneish M-Score
(Annual)
Level (-2.4625)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (1.7668)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Verisk Analytics is the leading provider of statistical, actuarial, and underwriting data for the United States’ property and casualty insurance industry. Verisk leverages a vast contributory database and proprietary data assets to develop analytical tools helping insurance providers to better assess and price risk, achieve operational efficiency and optimize claim settlement processes. While Verisk also offers tools to quantify costs after loss events occur and to detect fraudulent activity, it is expanding into adjacent markets of life insurance, marketing, and non-US operations.
Stock Forecast FAQ
In the current month, VRSK has received 4 Buy ratings 10 Hold ratings, and 0 Sell ratings. The VRSK average analyst price target in the past 3 months is $294.02.
-
Where Will Verisk Analytics Stock Be In 1 Year?
According to analysts, the consensus estimate is that Verisk Analytics share price will rise to $294.02 per share over the next 12 months.
-
What Do Analysts Say About Verisk Analytics?
Analysts are divided on their view about Verisk Analytics share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Verisk Analytics is a Sell and believe this share price will drop from its current level to $230.00.
-
What Is Verisk Analytics's Price Target?
The price target for Verisk Analytics over the next 1-year time period is forecast to be $294.02 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is VRSK A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Verisk Analytics is a Hold. 10 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of VRSK?
You can purchase shares of Verisk Analytics via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Verisk Analytics shares.
-
What Is The Verisk Analytics Share Price Today?
Verisk Analytics was last trading at $292.61 per share. This represents the most recent stock quote for Verisk Analytics. Yesterday, Verisk Analytics closed at $284.35 per share.
-
How To Buy Verisk Analytics Stock Online?
In order to purchase Verisk Analytics stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
